Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients-Reference-Cited by-同舟云学术

Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients

Published:2019-01-30 Issue:1 Volume:17 Page:87-93
ISSN:1598-9100
Container-title:Intestinal Research
language:en
Short-container-title:Intest Res

Author:

Yagisawa Keiji^ORCID,Kobayashi Taku^ORCID,Ozaki Ryo,Okabayashi Shinji,Toyonaga Takahiko,Miura Miki,Hayashida Mari,Saito Eiko,Nakano Masaru,Matsubara Hajime,Hisamatsu Tadakazu,Hibi Toshifumi

Publisher

Korean Association for the Study of Intestinal Diseases

Subject

Gastroenterology

Link

http://irjournal.org/upload/pdf/ir-2018-00078.pdf

Reference14 articles.

1. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

2. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis

3. Relationship between non-adherence to aminosalicylate medication and the risk of clinical relapse among Japanese patients with ulcerative colitis in clinical remission: a prospective cohort study

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuing or stopping 5‐aminosalicylates in patients with inflammatory bowel disease on anti‐TNF therapy: A nationwide population‐based study;Alimentary Pharmacology & Therapeutics;2024-06-12

2. A review on taste masked multiparticulate dosage forms for paediatric;International Journal of Pharmaceutics;2023-02

3. Medication Formulation Preference of Mild and Moderate Ulcerative Colitis Patients: a European Survey;Inflammatory Intestinal Diseases;2023

4. Efficacy and Safety of Vitamin D Adjuvant Therapy for Ulcerative Colitis: A Meta-Analysis;Computational and Mathematical Methods in Medicine;2022-07-20

5. Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review;Precision and Future Medicine;2021-12-31